Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Larry Dumont

Concepts (333)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Preservation
48
2025
346
10.350
Why?
Blood Platelets
31
2024
382
8.270
Why?
Platelet Transfusion
19
2023
76
3.510
Why?
Erythrocytes
25
2025
750
3.430
Why?
Blood Donors
13
2021
145
2.830
Why?
Cryopreservation
11
2023
115
2.810
Why?
Plateletpheresis
11
2024
28
2.110
Why?
Antibodies, Viral
9
2025
689
1.510
Why?
Dimethyl Sulfoxide
3
2023
42
1.170
Why?
Platelet-Rich Plasma
2
2023
44
1.080
Why?
Plasma
6
2014
222
1.070
Why?
Pharmaceutical Solutions
4
2014
14
1.010
Why?
Antibodies, Neutralizing
8
2025
348
1.000
Why?
Leukocyte Reduction Procedures
8
2025
29
0.960
Why?
Mannitol
4
2014
42
0.940
Why?
Hydrogen-Ion Concentration
12
2024
533
0.940
Why?
Membrane Lipids
3
2020
81
0.920
Why?
Sodium Chloride
4
2014
138
0.890
Why?
Glucose
8
2017
1053
0.870
Why?
Blood Component Removal
5
2022
26
0.850
Why?
ABO Blood-Group System
5
2020
56
0.830
Why?
Adenine
4
2014
339
0.780
Why?
Metabolome
4
2020
390
0.750
Why?
Erythrocyte Transfusion
9
2021
226
0.710
Why?
Glycolysis
5
2021
342
0.660
Why?
Metformin
1
2024
328
0.650
Why?
Cytoskeleton
1
2022
180
0.650
Why?
Humans
91
2025
146342
0.630
Why?
Time Factors
21
2023
7109
0.630
Why?
Adenosine Triphosphate
6
2015
494
0.620
Why?
Solutions
4
2014
160
0.570
Why?
Immunization, Passive
10
2025
90
0.550
Why?
Hemostasis
3
2021
100
0.540
Why?
Glutathione
2
2017
369
0.530
Why?
Erythrocyte Membrane
2
2020
55
0.530
Why?
Carrier Proteins
1
2022
728
0.530
Why?
Blood Transfusion, Autologous
3
2020
18
0.530
Why?
Cold Temperature
3
2020
208
0.510
Why?
Blood Grouping and Crossmatching
3
2016
19
0.500
Why?
Cell Survival
10
2017
1105
0.460
Why?
Blood Group Incompatibility
2
2012
21
0.450
Why?
Metabolomics
5
2021
738
0.450
Why?
Dexamethasone
1
2017
368
0.440
Why?
Leukocytes
3
2023
301
0.440
Why?
Phosphatidylserines
2
2014
62
0.430
Why?
Cell-Derived Microparticles
2
2018
73
0.420
Why?
Drug Delivery Systems
1
2017
377
0.400
Why?
Carbon Dioxide
1
2015
228
0.400
Why?
Blood Safety
3
2016
11
0.400
Why?
Erythrocyte Aggregation
1
2012
4
0.380
Why?
Transfusion Reaction
3
2022
61
0.370
Why?
Blood Proteins
1
2014
239
0.370
Why?
Citrates
4
2017
41
0.360
Why?
Oxidative Stress
5
2020
1369
0.360
Why?
Dicarboxylic Acids
1
2011
12
0.350
Why?
Polyvinyl Chloride
1
2011
12
0.350
Why?
Diethylhexyl Phthalate
1
2011
13
0.350
Why?
Cyclohexanecarboxylic Acids
1
2011
18
0.350
Why?
Bacteriological Techniques
2
2013
66
0.350
Why?
United States Food and Drug Administration
3
2016
208
0.350
Why?
Catheterization, Peripheral
1
2012
116
0.330
Why?
Rejuvenation
1
2011
18
0.330
Why?
Minerals
1
2011
48
0.320
Why?
Platelet Aggregation
3
2022
99
0.320
Why?
Energy Metabolism
2
2021
930
0.320
Why?
Randomized Controlled Trials as Topic
4
2023
1763
0.310
Why?
Interferon Type I
2
2021
147
0.310
Why?
Staphylococcus epidermidis
1
2010
80
0.310
Why?
Urinary Tract Infections
1
2012
209
0.310
Why?
Bacteremia
1
2012
218
0.310
Why?
Evidence-Based Practice
1
2012
231
0.310
Why?
Hematopoietic Stem Cell Transplantation
2
2022
704
0.300
Why?
Oxygen
3
2015
997
0.290
Why?
Anaerobiosis
4
2015
65
0.280
Why?
Testosterone
3
2022
419
0.280
Why?
Thrombocytopenia
2
2022
206
0.280
Why?
Hemolysis
7
2025
242
0.280
Why?
Hemostatics
2
2021
66
0.270
Why?
Citric Acid
3
2012
33
0.260
Why?
Bacteria
2
2013
766
0.260
Why?
Platelet Activation
2
2024
99
0.250
Why?
Seroepidemiologic Studies
3
2021
171
0.240
Why?
In Vitro Techniques
4
2021
1041
0.240
Why?
Leukapheresis
1
2006
27
0.240
Why?
Staphylococcal Infections
1
2010
397
0.230
Why?
Blood Banks
4
2020
50
0.230
Why?
Specimen Handling
1
2007
178
0.230
Why?
Photopheresis
2
2018
9
0.230
Why?
Lactic Acid
2
2024
295
0.230
Why?
Platelet Function Tests
2
2022
37
0.230
Why?
Adenosine Diphosphate
2
2022
75
0.230
Why?
Blood Transfusion
4
2016
394
0.220
Why?
Temperature
3
2014
635
0.220
Why?
Blood Coagulation Tests
2
2015
72
0.220
Why?
Serologic Tests
2
2022
50
0.210
Why?
Oxygen Consumption
2
2024
721
0.210
Why?
Platelet Count
4
2020
95
0.210
Why?
Anticoagulants
4
2014
746
0.210
Why?
Leukocytes, Mononuclear
2
2023
585
0.200
Why?
Male
26
2025
73396
0.200
Why?
2,3-Diphosphoglycerate
2
2015
32
0.200
Why?
Autoantibodies
2
2021
1500
0.200
Why?
Hemoglobins
4
2022
384
0.190
Why?
P-Selectin
3
2022
29
0.180
Why?
Xenon
1
2022
7
0.180
Why?
Neuroacanthocytosis
1
2022
5
0.180
Why?
Furocoumarins
1
2022
8
0.180
Why?
Refrigeration
1
2022
11
0.180
Why?
HMGB1 Protein
1
2022
51
0.180
Why?
Adult
17
2025
41087
0.180
Why?
Hormone Replacement Therapy
2
2021
107
0.180
Why?
Granulomatous Disease, Chronic
1
2022
49
0.180
Why?
Flow Cytometry
1
2006
1163
0.180
Why?
Hospital Distribution Systems
1
2021
1
0.180
Why?
Compassionate Use Trials
1
2021
7
0.180
Why?
Female
21
2025
79499
0.170
Why?
Radioisotopes
3
2008
37
0.170
Why?
Middle Aged
15
2025
36619
0.170
Why?
Aged
13
2025
26432
0.160
Why?
Healthy Volunteers
2
2021
218
0.160
Why?
Bone Marrow Transplantation
1
2022
301
0.160
Why?
Nonprescription Drugs
1
2021
68
0.160
Why?
Organ Preservation Solutions
2
2012
47
0.160
Why?
Adolescent
8
2021
22557
0.150
Why?
Taurine
1
2020
41
0.150
Why?
Health Services Needs and Demand
1
2021
287
0.150
Why?
Prescription Drugs
1
2021
110
0.150
Why?
Antibodies, Monoclonal
2
2016
1512
0.140
Why?
Cryoprotective Agents
2
2018
11
0.140
Why?
Cooperative Behavior
3
2012
471
0.140
Why?
Asparagine
1
2018
34
0.140
Why?
Freezing
1
2018
83
0.140
Why?
Feasibility Studies
1
2023
1135
0.140
Why?
Oxidation-Reduction
3
2021
1075
0.140
Why?
Cigarette Smoking
1
2020
103
0.140
Why?
Aspartic Acid
1
2018
88
0.140
Why?
Product Packaging
2
2011
6
0.140
Why?
Blood Buffy Coat
1
2018
6
0.140
Why?
Host-Pathogen Interactions
1
2021
366
0.130
Why?
Buffers
2
2014
56
0.130
Why?
Lymphoma, T-Cell, Cutaneous
1
2018
43
0.130
Why?
Aged, 80 and over
5
2021
8391
0.130
Why?
Nicotine
1
2020
337
0.130
Why?
Extracorporeal Membrane Oxygenation
1
2021
370
0.130
Why?
Chromatography, Liquid
2
2021
453
0.120
Why?
Pentose Phosphate Pathway
1
2017
55
0.120
Why?
Immunoglobulin G
1
2021
901
0.120
Why?
Dithiothreitol
1
2016
19
0.120
Why?
Histocompatibility Testing
1
2016
124
0.120
Why?
Government Regulation
1
2016
38
0.120
Why?
Platelet Adhesiveness
1
2015
14
0.110
Why?
Severity of Illness Index
2
2021
2921
0.110
Why?
Guidelines as Topic
2
2020
267
0.110
Why?
Tandem Mass Spectrometry
2
2021
576
0.110
Why?
Protein Processing, Post-Translational
1
2018
487
0.110
Why?
Transfusion Medicine
1
2015
20
0.110
Why?
Heart-Assist Devices
1
2021
572
0.110
Why?
Young Adult
8
2021
14330
0.110
Why?
False Positive Reactions
2
2016
124
0.110
Why?
Cardiac Surgical Procedures
1
2021
611
0.110
Why?
Metabolic Networks and Pathways
1
2016
175
0.110
Why?
Monocytes
1
2018
538
0.110
Why?
Cross-Over Studies
3
2012
615
0.110
Why?
Therapeutic Equivalency
1
2014
31
0.110
Why?
Gases
1
2014
45
0.110
Why?
Hematocrit
1
2014
108
0.100
Why?
Osmolar Concentration
1
2014
165
0.100
Why?
United States
8
2021
16136
0.100
Why?
False Negative Reactions
2
2011
61
0.100
Why?
Colony Count, Microbial
2
2011
90
0.100
Why?
Blood Coagulation Factors
1
2014
71
0.100
Why?
Gas Chromatography-Mass Spectrometry
1
2014
124
0.100
Why?
Blood Coagulation
1
2015
267
0.100
Why?
Disease Progression
1
2021
2867
0.100
Why?
Hemorrhage
1
2018
825
0.090
Why?
Registries
1
2021
2400
0.090
Why?
Vaccination
1
2021
1449
0.090
Why?
Hematologic Neoplasms
2
2018
170
0.090
Why?
Phosphoric Acids
1
2012
14
0.090
Why?
Single-Blind Method
3
2021
313
0.090
Why?
Microscopy, Electron, Transmission
1
2012
150
0.090
Why?
Treatment Outcome
6
2025
11821
0.090
Why?
Nitrogen Mustard Compounds
1
2011
9
0.090
Why?
Checklist
1
2012
105
0.080
Why?
Bacteria, Aerobic
1
2011
7
0.080
Why?
Acridines
1
2011
10
0.080
Why?
Bacteria, Anaerobic
1
2011
25
0.080
Why?
Immunity, Humoral
2
2023
121
0.080
Why?
Heparin
1
2012
247
0.080
Why?
Klebsiella oxytoca
1
2010
1
0.080
Why?
Viridans Streptococci
1
2010
7
0.080
Why?
Serratia Infections
1
2010
8
0.080
Why?
Preservatives, Pharmaceutical
1
2011
28
0.080
Why?
Serratia marcescens
1
2010
17
0.080
Why?
Klebsiella Infections
1
2010
26
0.080
Why?
Adaptive Immunity
2
2023
173
0.080
Why?
Delphi Technique
1
2012
350
0.080
Why?
Kinetics
1
2014
1553
0.080
Why?
Consensus
1
2012
467
0.080
Why?
Sensitivity and Specificity
2
2022
1998
0.080
Why?
Cell Membrane
1
2014
701
0.080
Why?
Erythrocyte Count
2
2007
20
0.080
Why?
Obesity
2
2020
3131
0.080
Why?
Escherichia coli Infections
1
2010
125
0.080
Why?
Graft vs Host Disease
1
2012
283
0.080
Why?
Regression Analysis
1
2012
999
0.080
Why?
Analysis of Variance
1
2012
1298
0.070
Why?
RNA, Viral
2
2025
693
0.070
Why?
Drug Combinations
1
2011
400
0.070
Why?
Biopsy, Fine-Needle
1
2009
79
0.070
Why?
Mice
5
2021
18297
0.070
Why?
Publishing
1
2010
117
0.070
Why?
Leukocyte Count
2
2007
321
0.070
Why?
Thyroid Nodule
1
2009
67
0.070
Why?
Genetic Heterogeneity
1
2009
67
0.070
Why?
Thrombosis
1
2012
398
0.070
Why?
Hospitalization
3
2025
2475
0.070
Why?
Lipids
1
2014
714
0.070
Why?
Safety Management
1
2009
130
0.070
Why?
Streptococcal Infections
1
2010
179
0.070
Why?
Mice, Inbred C57BL
2
2021
6034
0.060
Why?
Ultraviolet Rays
2
2022
376
0.060
Why?
Transportation
1
2007
54
0.060
Why?
Proteome
1
2012
520
0.060
Why?
Animals
6
2022
38106
0.060
Why?
Cell Separation
1
2007
300
0.060
Why?
Escherichia coli
1
2010
832
0.060
Why?
Staphylococcus aureus
1
2010
459
0.060
Why?
Research Design
1
2012
1143
0.060
Why?
Survival Analysis
1
2009
1378
0.060
Why?
Risk Assessment
2
2012
3712
0.060
Why?
Practice Guidelines as Topic
1
2012
1591
0.050
Why?
Genotype
1
2009
1879
0.050
Why?
Pregnancy
1
2017
7230
0.050
Why?
Prevalence
2
2021
2861
0.050
Why?
Quality Control
2
2016
163
0.050
Why?
Neutralization Tests
1
2023
74
0.050
Why?
Blood Gas Analysis
1
2003
80
0.050
Why?
CD40 Ligand
1
2022
32
0.050
Why?
Blood Cell Count
1
2002
56
0.050
Why?
Clinical Trials as Topic
1
2008
1064
0.050
Why?
Glycerol
1
2022
90
0.040
Why?
Spike Glycoprotein, Coronavirus
1
2023
129
0.040
Why?
Prospective Studies
3
2022
8123
0.040
Why?
Masculinity
1
2021
10
0.040
Why?
Retrospective Studies
4
2020
17438
0.040
Why?
Macaca mulatta
1
2022
188
0.040
Why?
Convalescence
1
2021
19
0.040
Why?
Ranitidine
1
2021
14
0.040
Why?
Thrombin
1
2022
175
0.040
Why?
Medically Underserved Area
1
2021
102
0.040
Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2021
51
0.040
Why?
Public Health Surveillance
1
2021
84
0.040
Why?
Hematologic Tests
1
2020
22
0.040
Why?
Osmotic Pressure
1
2020
41
0.040
Why?
Ferritins
1
2020
69
0.040
Why?
Coronavirus
1
2021
47
0.040
Why?
Treatment Failure
1
2021
361
0.040
Why?
Infusions, Intravenous
1
2021
432
0.040
Why?
Signal Transduction
1
2014
5246
0.040
Why?
Polycythemia
1
2020
25
0.040
Why?
Double-Blind Method
1
2025
2070
0.040
Why?
Software
1
2005
676
0.040
Why?
Graft Survival
1
2002
523
0.040
Why?
Outpatients
1
2023
440
0.040
Why?
Hypogonadism
1
2020
89
0.040
Why?
Platelet Glycoprotein GPIb-IX Complex
1
2018
2
0.040
Why?
High-Throughput Screening Assays
1
2021
179
0.040
Why?
Mice, Inbred NOD
1
2020
598
0.040
Why?
Estradiol
1
2022
517
0.030
Why?
Health Care Surveys
1
2020
541
0.030
Why?
Methoxsalen
1
2018
4
0.030
Why?
Phytohemagglutinins
1
2018
29
0.030
Why?
Annexin A5
1
2018
23
0.030
Why?
Developing Countries
1
2020
312
0.030
Why?
Patient Safety
1
2021
352
0.030
Why?
Methylation
1
2018
241
0.030
Why?
Child
3
2022
22693
0.030
Why?
Tissue Donors
1
2021
425
0.030
Why?
Inpatients
1
2021
540
0.030
Why?
Thrombelastography
1
2018
182
0.030
Why?
Cytokines
1
2025
2081
0.030
Why?
Child, Preschool
2
2022
11913
0.030
Why?
Methods
1
2016
68
0.030
Why?
ADP-ribosyl Cyclase 1
1
2016
43
0.030
Why?
Cross Reactions
1
2016
130
0.030
Why?
Blotting, Western
1
2018
1177
0.030
Why?
Logistic Models
1
2021
2126
0.030
Why?
Antiviral Agents
1
2022
779
0.030
Why?
Hemorheology
1
2015
24
0.030
Why?
Nitric Oxide
1
2020
883
0.030
Why?
Erythrocyte Deformability
1
2015
23
0.030
Why?
Biochemistry
1
2015
36
0.030
Why?
Immunoglobulins, Intravenous
1
2016
134
0.030
Why?
Socioeconomic Factors
1
2020
1327
0.030
Why?
Mice, Inbred Strains
1
2016
384
0.030
Why?
Chromium Radioisotopes
1
2014
4
0.030
Why?
Machine Learning
1
2021
594
0.030
Why?
Species Specificity
1
2016
543
0.030
Why?
Perfusion
1
2015
255
0.030
Why?
Antibodies
1
2016
400
0.030
Why?
Genetic Association Studies
1
2016
379
0.030
Why?
Bacterial Infections
1
2016
247
0.030
Why?
Models, Theoretical
2
2009
561
0.020
Why?
Mice, Knockout
1
2021
3125
0.020
Why?
Models, Biological
1
2021
1761
0.020
Why?
Pandemics
1
2021
1707
0.020
Why?
Veterans
1
2025
1650
0.020
Why?
Antioxidants
1
2016
544
0.020
Why?
Case-Control Studies
1
2020
3647
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2012
109
0.020
Why?
Body Mass Index
1
2020
2458
0.020
Why?
Proteomics
1
2018
1203
0.020
Why?
Hospitals
1
2016
738
0.020
Why?
Cell Proliferation
1
2018
2502
0.020
Why?
Cells, Cultured
1
2018
4118
0.020
Why?
Biomarkers
1
2021
4340
0.020
Why?
Drug Therapy, Combination
1
2012
1036
0.020
Why?
Apoptosis
1
2018
2439
0.020
Why?
Emergency Service, Hospital
1
2021
2363
0.020
Why?
Diphosphoglyceric Acids
1
2008
3
0.020
Why?
Alkalies
1
2008
5
0.020
Why?
Aerobiosis
1
2008
18
0.020
Why?
Automation
1
2007
104
0.020
Why?
Risk Factors
1
2021
10921
0.020
Why?
Odds Ratio
1
2009
1077
0.020
Why?
Equipment Design
1
2007
520
0.010
Why?
Evaluation Studies as Topic
1
2005
161
0.010
Why?
Acute Lung Injury
1
2009
312
0.010
Why?
Computer Simulation
1
2009
1014
0.010
Why?
Pilot Projects
1
2008
1888
0.010
Why?
Sepsis
1
2009
669
0.010
Why?
Cohort Studies
1
2009
6077
0.010
Why?
Dumont's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)